EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m6A modification-mediated RNA stability control

Yimeng Gao, Joshua T Zimmer, Radovan Vasic, Chengyang Liu, Rana Gbyli, Shu-Jian Zheng, Amisha Patel, Wei Liu, Zhihong Qi, Yaping Li, Raman Nelakanti, Yuanbin Song und 9 weitere

Cell Reports · 2023

DOI: 10.1016/j.celrep.2023.113163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Yimeng Gao und 20 weiteren Autor:innen. Beteiligte Einrichtung: Section of Hematology, Department of Internal Medicine, Yale Cancer Center, and Yale Center for RNA Science and Medicine, Yale University School of M…. Hauptthemen laut MEDLINE: Leukemia, RNA. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, Howard Hughes Medical Institute, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N6-methyladenosine (m6A) RNA modification controls numerous cellular processes. To what extent these post-transcriptional regulatory mechanisms play a role in hematopoiesis has not been fully elucidated. We here show that the m6A demethylase alkB homolog 5 (ALKBH5) controls mitochondrial ATP production and modulates hematopoietic stem and progenitor cell (HSPC) fitness in an m6A-dependent manner. Loss of ALKBH5 results in increased RNA methylation and instability of oxoglutarate-dehydrogenase (Ogdh) messenger RNA and reduction of OGDH protein levels. Limited OGDH availability slows the tricarboxylic acid (TCA) cycle with accumulation of α-ketoglutarate (α-KG) and conversion of α-KG into L-2-hydroxyglutarate (L-2-HG). L-2-HG inhibits energy production in both murine and human hematopoietic cells in vitro. Impaired mitochondrial energy production confers competitive disadvantage to HSPCs and limits clonogenicity of Mll-AF9-induced leukemia. Our study uncovers a mechanism whereby the RNA m6A demethylase ALKBH5 regulates the stability of metabolic enzyme transcripts, thereby controlling energy metabolism in hematopoiesis and leukemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeukemiaRNAAnimalsHumansMiceAlkB Homolog 5, RNA DemethylaseEnergy MetabolismHematopoietic Stem CellsRNA Stability

Stichwörter der Autor:innen

ALKBH5ATP productionCP: Molecular biologyCP: Stem cell researchOXPHOSRNA stabilityenergy metabolismhematopoietic stem and progenitor cellsleukemiam(6)A modificationoxidative phosphorylationstress hematopoiesis

Substanzen

AlkB Homolog 5, RNA DemethylaseALKBH5 protein, humanRNAALKBH5 protein, mouse

Autor:innen und Institutionen

  • Section of Hematology, Department of Internal Medicine, Yale Cancer Center, and Yale Center for RNA Science and Medicine, Yale University School of Medicine, New Haven, CT 06520, USA; Yale Stem Cell Center, Yale Univers…
  • Department of Molecular Biophysics & Biochemistry, Yale University, New Haven, CT 06511, USA; Institute for Biomolecular Design and Discovery, Yale University, West Haven, CT 06516, USA.
  • Institute for Biomolecular Design and Discovery, Yale University, West Haven, CT 06516, USA; Department of Chemistry, Yale University, New Haven, CT 06520, USA.
  • Department of Genetics and Yale Stem Cell Center, Yale School of Medicine, New Haven, CT 06520, USA.
  • Department of Molecular Biophysics & Biochemistry, Yale University, New Haven, CT 06511, USA; Institute for Biomolecular Design and Discovery, Yale University, West Haven, CT 06516, USA; Department of Chemistry, Yale Un…
  • Department of Internal Medicine, Yale University, New Haven, CT 06520, USA; Department of Cellular & Molecular Physiology, Yale University, New Haven, CT 06520, USA.

Förderung

  • NCATS NIH HHS
  • Howard Hughes Medical Institute
  • NIDDK NIH HHS
  • NIH HHS
  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Cancer Institute
  • National Institute of General Medical Sciences

Zitieren

APA

Gao, Y., Zimmer, J. T., Vasic, R., Liu, C., Gbyli, R., Zheng, S. J., Patel, A., Liu, W., Qi, Z., Li, Y., Nelakanti, R., Song, Y., Biancon, G., Xiao, A. Z., Slavoff, S., Kibbey, R. G., Flavell, R. A., Simon, M. D., Tebaldi, T., …, & Halene, S. (2023). ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m6A modification-mediated RNA stability control. Cell Reports. https://doi.org/10.1016/j.celrep.2023.113163

Vancouver

Gao Y, Zimmer JT, Vasic R, Liu C, Gbyli R, Zheng SJ, et al. ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m6A modification-mediated RNA stability control. Cell Reports. 2023. doi:10.1016/j.celrep.2023.113163

BibTeX
@article{Gao2023,
  author = {Gao, Yimeng and Zimmer, Joshua T and Vasic, Radovan and Liu, Chengyang and Gbyli, Rana and Zheng, Shu-Jian and Patel, Amisha and Liu, Wei and Qi, Zhihong and Li, Yaping and Nelakanti, Raman and Song, Yuanbin and Biancon, Giulia and Xiao, Andrew Z and Slavoff, Sarah and Kibbey, Richard G and Flavell, Richard A and Simon, Matthew D and Tebaldi, Toma and Li, Hua-Bing and Halene, Stephanie},
  title = {ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m6A modification-mediated RNA stability control},
  journal = {Cell Reports},
  year = {2023},
  doi = {10.1016/j.celrep.2023.113163}
}
Kostenlos starten →